Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Burkett

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Radiology. Imaging Cancer|November 18, 2022
Normalized Dynamic Contrast-enhanced Perfusion and Diffusion-weighted MRI Parameters Distinguish Head and Neck Cancer Recurrence from Posttreatment ChangesBrian J Burkett
Radiology. Imaging Cancer|July 29, 2022
LuPIN Substudy of Posttreatment PET after <sup>177</sup>Lu-PSMA-617 with NOX66: Prognostic Value of FDG and PSMABrian J Burkett
Radiology. Imaging Cancer|November 26, 2021
Radioligand Therapy for Metastatic Prostate CancerBrian J Burkett
Radiology. Imaging Cancer|March 25, 2022
7-T Sodium MRI for Intracranial Tumor Response Assessment after Stereotactic RadiosurgeryBrian J Burkett
Radiology. Imaging Cancer|March 31, 2023
Single-Time-Point Dosimetry of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy with SPECT/CTBrian J Burkett
Ohio Medicine : Journal of the Ohio State Medical Association|July 1, 1988
Combining psychotherapy and psychochemotherapyT Bonstedt, J Burkett
Radiology. Imaging Cancer|October 10, 2025
7-T MRSI Mapping of Glutamate and Glutamine in Diffuse GliomasBrian J Burkett, John Port
Neurosurgery Clinics of North America|November 14, 2024
A Critical Review of Endoscopic Spine SurgeryDaniel J Burkett, Nathaniel Brooks
Radiology. Imaging Cancer|January 21, 2025
Molecular Imaging of Paragangliomas and PheochromocytomasBrian J Burkett, Derek R Johnson
Yeast (Chichester, England)|January 1, 1994
Molecular characterization of the SPT23 gene: a dosage-dependent suppressor of Ty-induced promoter mutations from Saccharomyces cerevisiaeT J Burkett, D J Garfinkel
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Radiology. Imaging Cancer|November 18, 2022
Normalized Dynamic Contrast-enhanced Perfusion and Diffusion-weighted MRI Parameters Distinguish Head and Neck Cancer Recurrence from Posttreatment ChangesBrian J Burkett
Radiology. Imaging Cancer|July 29, 2022
LuPIN Substudy of Posttreatment PET after <sup>177</sup>Lu-PSMA-617 with NOX66: Prognostic Value of FDG and PSMABrian J Burkett
Radiology. Imaging Cancer|November 26, 2021
Radioligand Therapy for Metastatic Prostate CancerBrian J Burkett
Radiology. Imaging Cancer|March 25, 2022
7-T Sodium MRI for Intracranial Tumor Response Assessment after Stereotactic RadiosurgeryBrian J Burkett
Radiology. Imaging Cancer|March 31, 2023
Single-Time-Point Dosimetry of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy with SPECT/CTBrian J Burkett
Ohio Medicine : Journal of the Ohio State Medical Association|July 1, 1988
Combining psychotherapy and psychochemotherapyT Bonstedt, J Burkett
Radiology. Imaging Cancer|October 10, 2025
7-T MRSI Mapping of Glutamate and Glutamine in Diffuse GliomasBrian J Burkett, John Port
Neurosurgery Clinics of North America|November 14, 2024
A Critical Review of Endoscopic Spine SurgeryDaniel J Burkett, Nathaniel Brooks
Radiology. Imaging Cancer|January 21, 2025
Molecular Imaging of Paragangliomas and PheochromocytomasBrian J Burkett, Derek R Johnson
Yeast (Chichester, England)|January 1, 1994
Molecular characterization of the SPT23 gene: a dosage-dependent suppressor of Ty-induced promoter mutations from Saccharomyces cerevisiaeT J Burkett, D J Garfinkel
Pageof 12